Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Goodwill - Additional Information (Details)

v3.25.0.1
Goodwill - Additional Information (Details)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Disclosure Of Reconciliation Of Changes In Goodwill [Line Items]    
Growth rate 1.00%  
Bottom of Range    
Disclosure Of Reconciliation Of Changes In Goodwill [Line Items]    
Growth rate 0.00%  
Percentage of average contraction of EBITDA at continuing value (20.00%)  
Top of Range    
Disclosure Of Reconciliation Of Changes In Goodwill [Line Items]    
Growth rate 3.00%  
Percentage of average contraction of EBITDA at continuing value 20.00%  
Biopharmaceutical and Diagnostic Solutions    
Disclosure Of Reconciliation Of Changes In Goodwill [Line Items]    
Discount rate 7.40% 7.70%
Percentage of average contraction of EBITDA at continuing value 41.90%  
Biopharmaceutical and Diagnostic Solutions | Bottom of Range    
Disclosure Of Reconciliation Of Changes In Goodwill [Line Items]    
Discount rate 6.40%  
Biopharmaceutical and Diagnostic Solutions | Top of Range    
Disclosure Of Reconciliation Of Changes In Goodwill [Line Items]    
Discount rate 8.40%  
Biopharmaceutical and Diagnostic Solutions | Weighted Average Cost of Capital, Measurement Input    
Disclosure Of Reconciliation Of Changes In Goodwill [Line Items]    
Further sensitivity analysis resulted in identification of breakeven 13.40%  
Engineering Systems    
Disclosure Of Reconciliation Of Changes In Goodwill [Line Items]    
Discount rate 6.70% 7.50%
Percentage of average contraction of EBITDA at continuing value 85.90%  
Engineering Systems | Bottom of Range    
Disclosure Of Reconciliation Of Changes In Goodwill [Line Items]    
Discount rate 5.70%  
Engineering Systems | Top of Range    
Disclosure Of Reconciliation Of Changes In Goodwill [Line Items]    
Discount rate 7.70%  
Engineering Systems | Weighted Average Cost of Capital, Measurement Input    
Disclosure Of Reconciliation Of Changes In Goodwill [Line Items]    
Further sensitivity analysis resulted in identification of breakeven 17.90%